TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CYTK

Cytokinetics Inc

Healthcare · Biotechnology

68.80$ -1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 32 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CYTK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.4 1.7 0.8 0.2 0.5 17 1.6 67 1.9 18 19 32 71
83 85 82 80 85 94 100 2.3 2.7 2.9 2.4 2.7 11
-82 -83 -81 -79 -84 -77 -98 64 -0.7 15 17 29 60
83 85 82 80 85 94 100 113 99 102 96 98 394
40 44 46 51 57 62 57 66 69 92 105 104 370
40 44 46 51 57 62 57 176 166 193 201 205 765
-122 -127 -126 -130 -141 -139 -156 -112 -167 -178 -184 -176 -705
14 17 17 24 22 23 23 24 26 30 33 35 125
-129 -137 -136 -143 -161 -150 -161 -134 -306 -183 -206 -199 -894
6.9 1.8 2.3
-129 -137 -136 -143 -161 -150 -161 -134 -306 -183 -206 -199 -894
-114 -113 -116 -117 -136 -125 -136 -108 -277 -180 -169 -192 -819

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?